Literature DB >> 22015769

Transglutaminase 2: a molecular Swiss army knife.

Soner Gundemir1, Gozde Colak, Janusz Tucholski, Gail V W Johnson.   

Abstract

Transglutaminase 2 (TG2) is the most widely distributed member of the transglutaminase family with almost all cell types in the body expressing TG2 to varying extents. In addition to being widely expressed, TG2 is an extremely versatile protein exhibiting transamidating, protein disulphide isomerase and guanine and adenine nucleotide binding and hydrolyzing activities. TG2 can also act as a protein scaffold or linker. This unique protein also undergoes extreme conformational changes and exhibits localization diversity. Being mainly a cytosolic protein; it is also found in the nucleus, associated with the cell membrane (inner and outer side) and with the mitochondria, and also in the extracellular matrix. These different activities, conformations and localization need to be carefully considered while assessing the role of TG2 in physiological and pathological processes. For example, it is becoming evident that the role of TG2 in cell death processes is dependent upon the cell type, stimuli, subcellular localization and conformational state of the protein. In this review we discuss in depth the conformational and functional diversity of TG2 in the context of its role in numerous cellular processes. In particular, we have highlighted how differential localization, conformation and activities of TG2 may distinctly mediate cell death processes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015769      PMCID: PMC3265640          DOI: 10.1016/j.bbamcr.2011.09.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  172 in total

1.  Roles of calcium ions in the activation and activity of the transglutaminase 3 enzyme.

Authors:  Bijan Ahvazi; Karen M Boeshans; William Idler; Ulrich Baxa; Peter M Steinert
Journal:  J Biol Chem       Date:  2003-04-04       Impact factor: 5.157

2.  A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis.

Authors:  Elisabetta A M Verderio; Dilek Telci; Afam Okoye; Gerry Melino; Martin Griffin
Journal:  J Biol Chem       Date:  2003-05-05       Impact factor: 5.157

3.  A novel function of tissue-type transglutaminase: protein disulphide isomerase.

Authors:  Go Hasegawa; Motoi Suwa; Yasuo Ichikawa; Tetsuro Ohtsuka; Satoru Kumagai; Masashi Kikuchi; Yoshitaka Sato; Yuji Saito
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

4.  Increased expression of tissue-type transglutaminase following middle cerebral artery occlusion in rats.

Authors:  Paul J Tolentino; Anuradha Waghray; Kevin K W Wang; Ronald L Hayes
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

5.  Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death.

Authors:  Tamara Milakovic; Janusz Tucholski; Eric McCoy; Gail V W Johnson
Journal:  J Biol Chem       Date:  2003-12-11       Impact factor: 5.157

6.  Identification of tissue transglutaminase as a novel molecule involved in human CD8+ T cell transendothelial migration.

Authors:  Karkada Mohan; Devanand Pinto; Thomas B Issekutz
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

7.  Tissue transglutaminase directly regulates adenylyl cyclase resulting in enhanced cAMP-response element-binding protein (CREB) activation.

Authors:  Janusz Tucholski; Gail V W Johnson
Journal:  J Biol Chem       Date:  2003-05-12       Impact factor: 5.157

8.  Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells.

Authors:  Zsuzsa Szondy; Zsolt Sarang; Peter Molnar; Tamas Nemeth; Mauro Piacentini; Pier Giorgio Mastroberardino; Laura Falasca; Daniel Aeschlimann; Judit Kovacs; Ildiko Kiss; Eva Szegezdi; Gabriella Lakos; Eva Rajnavolgyi; Paul J Birckbichler; Gerry Melino; Laszlo Fesus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-16       Impact factor: 11.205

Review 9.  Properties and applications of microbial transglutaminase.

Authors:  K Yokoyama; N Nio; Y Kikuchi
Journal:  Appl Microbiol Biotechnol       Date:  2004-01-22       Impact factor: 4.813

10.  Structural basis for the coordinated regulation of transglutaminase 3 by guanine nucleotides and calcium/magnesium.

Authors:  Bijan Ahvazi; Karen M Boeshans; William Idler; Ulrich Baxa; Peter M Steinert; Fraydoon Rastinejad
Journal:  J Biol Chem       Date:  2003-11-28       Impact factor: 5.157

View more
  91 in total

1.  Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.

Authors:  Matthew L Fisher; Jeffrey W Keillor; Wen Xu; Richard L Eckert; Candace Kerr
Journal:  Mol Cancer Res       Date:  2015-05-01       Impact factor: 5.852

2.  The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.

Authors:  M Cheng; P He; J Fu
Journal:  J Hum Hypertens       Date:  2016-05-12       Impact factor: 3.012

3.  Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.

Authors:  Chi Hua Sarah Lin; Jun Chen; Zhongtao Zhang; Gail V W Johnson; Arthur J L Cooper; Julianne Feola; Alexander Bank; Jonathan Shein; Heli J Ruotsalainen; Taina A Pihlajaniemi; Michael S Goligorsky
Journal:  Kidney Int       Date:  2016-04-14       Impact factor: 10.612

4.  An unprecedented dual antagonist and agonist of human Transglutaminase 2.

Authors:  Michael C Yi; Brad A Palanski; Steven A Quintero; Nicholas M Plugis; Chaitan Khosla
Journal:  Bioorg Med Chem Lett       Date:  2015-05-15       Impact factor: 2.823

5.  Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.

Authors:  Laura Yunes-Medina; Julianne Feola; Gail V W Johnson
Journal:  Neuroreport       Date:  2017-12-13       Impact factor: 1.837

6.  Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.

Authors:  Julianne Feola; Alan Barton; Abdullah Akbar; Jeffrey Keillor; Gail V W Johnson
Journal:  Brain Res       Date:  2017-05-15       Impact factor: 3.252

7.  Selective inhibition of extracellular thioredoxin by asymmetric disulfides.

Authors:  Thomas R DiRaimondo; Nicholas M Plugis; Xi Jin; Chaitan Khosla
Journal:  J Med Chem       Date:  2013-01-31       Impact factor: 7.446

8.  TG2 regulates the heat-shock response by the post-translational modification of HSF1.

Authors:  Federica Rossin; Valeria Rachela Villella; Manuela D'Eletto; Maria Grazia Farrace; Speranza Esposito; Eleonora Ferrari; Romina Monzani; Luca Occhigrossi; Vittoria Pagliarini; Claudio Sette; Giorgio Cozza; Nikolai A Barlev; Laura Falasca; Gian Maria Fimia; Guido Kroemer; Valeria Raia; Luigi Maiuri; Mauro Piacentini
Journal:  EMBO Rep       Date:  2018-05-11       Impact factor: 8.807

9.  Structure-Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase.

Authors:  Abdullah Akbar; Nicole M R McNeil; Marie R Albert; Viviane Ta; Gautam Adhikary; Karine Bourgeois; Richard L Eckert; Jeffrey W Keillor
Journal:  J Med Chem       Date:  2017-09-14       Impact factor: 7.446

Review 10.  Transglutaminase is a tumor cell and cancer stem cell survival factor.

Authors:  Richard L Eckert; Matthew L Fisher; Dan Grun; Gautam Adhikary; Wen Xu; Candace Kerr
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.